Literature DB >> 27402750

Equity and length of lifespan are not the same.

Benjamin Seligman1, Gabi Greenberg2, Shripad Tuljapurkar3.   

Abstract

Efforts to understand the dramatic declines in mortality over the past century have focused on life expectancy. However, understanding changes in disparity in age of death is important to understanding mechanisms of mortality improvement and devising policy to promote health equity. We derive a novel decomposition of variance in age of death, a measure of inequality, and apply it to cause-specific contributions to the change in variance among the G7 countries (Canada, France, Germany, Italy, Japan, the United Kingdom, and the United States) from 1950 to 2010. We find that the causes of death that contributed most to declines in the variance are different from those that contributed most to increase in life expectancy; in particular, they affect mortality at younger ages. We also find that, for two leading causes of death [cancers and cardiovascular disease (CVD)], there are no consistent relationships between changes in life expectancy and variance either within countries over time or between countries. These results show that promoting health at younger ages is critical for health equity and that policies to control cancer and CVD may have differing implications for equity.

Entities:  

Keywords:  age of death variance; health equity; inequality; life expectancy; mortality

Mesh:

Year:  2016        PMID: 27402750      PMCID: PMC4968733          DOI: 10.1073/pnas.1601112113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  How did cause of death contribute to racial differences in life expectancy in the United States in 2010?

Authors:  Kenneth D Kochanek; Elizabeth Arias; Robert N Anderson
Journal:  NCHS Data Brief       Date:  2013-07

2.  Contribution of cause-specific mortality to changing sex differences in life expectancy: seven nations case study.

Authors:  F Trovato; N M Lalu
Journal:  Soc Biol       Date:  1998 Spring-Summer

Review 3.  Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s?

Authors:  Martin O'Flaherty; Iain Buchan; Simon Capewell
Journal:  Heart       Date:  2012-09-09       Impact factor: 5.994

4.  The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases.

Authors:  S J Olshansky; A B Ault
Journal:  Milbank Q       Date:  1986       Impact factor: 4.911

5.  The epidemiologic transition. A theory of the epidemiology of population change.

Authors:  A R Omran
Journal:  Milbank Mem Fund Q       Date:  1971-10

6.  The burden of disease among the global poor.

Authors:  D R Gwatkin; M Guillot; P Heuveline
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

7.  Sex mortality differences in the United States: the role of cohort smoking patterns.

Authors:  Samuel H Preston; Haidong Wang
Journal:  Demography       Date:  2006-11

Review 8.  Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care.

Authors:  Earl S Ford; Simon Capewell
Journal:  Annu Rev Public Health       Date:  2011       Impact factor: 21.981

9.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

10.  Why lifespans are more variable among blacks than among whites in the United States.

Authors:  Glenn Firebaugh; Francesco Acciai; Aggie J Noah; Christopher Prather; Claudia Nau
Journal:  Demography       Date:  2014-12
View more
  10 in total

1.  Longevity and Lifespan Variation by Educational Attainment in Spain: 1960-2015.

Authors:  Iñaki Permanyer; Jeroen Spijker; Amand Blanes; Elisenda Renteria
Journal:  Demography       Date:  2018-12

2.  Potential gains in life expectancy by reducing inequality of lifespans in Denmark: an international comparison and cause-of-death analysis.

Authors:  José Manuel Aburto; Maarten Wensink; Alyson van Raalte; Rune Lindahl-Jacobsen
Journal:  BMC Public Health       Date:  2018-07-04       Impact factor: 3.295

3.  Lifespan Dispersion in Times of Life Expectancy Fluctuation: The Case of Central and Eastern Europe.

Authors:  José Manuel Aburto; Alyson van Raalte
Journal:  Demography       Date:  2018-12

4.  Global trends in lifespan inequality: 1950-2015.

Authors:  Iñaki Permanyer; Nathalie Scholl
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

5.  Normalized lifespan inequality: disentangling the longevity-lifespan variability nexus.

Authors:  Iñaki Permanyer; Jiaxin Shi
Journal:  Genus       Date:  2022-01-10

6.  Urban-rural lifespan disparities and cause-deleted analysis: evidence from China.

Authors:  Mengxue Chen; Vladimir Canudas-Romo
Journal:  BMJ Open       Date:  2022-02-15       Impact factor: 2.692

7.  Significant impacts of the COVID-19 pandemic on race/ethnic differences in US mortality.

Authors:  José Manuel Aburto; Andrea M Tilstra; Ginevra Floridi; Jennifer Beam Dowd
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-23       Impact factor: 12.779

8.  Diversification in causes of death in low-mortality countries: emerging patterns and implications.

Authors:  Marie-Pier Bergeron-Boucher; José Manuel Aburto; Alyson van Raalte
Journal:  BMJ Glob Health       Date:  2020-07

9.  Dynamics of life expectancy and life span equality.

Authors:  José Manuel Aburto; Francisco Villavicencio; Ugofilippo Basellini; Søren Kjærgaard; James W Vaupel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

10.  Assessing the contribution of alcohol-specific causes to socio-economic inequalities in mortality in England and Wales 2001-16.

Authors:  Colin Angus; Rob Pryce; John Holmes; Frank de Vocht; Matthew Hickman; Petra Meier; Alan Brennan; Duncan Gillespie
Journal:  Addiction       Date:  2020-03-31       Impact factor: 6.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.